The PHE newborn blood spot (NBS) screening team has analysed results from its evaluation survey of the newborn blood spot failsafe solution.
NHS Newborn Blood Spot Screening Programme
New national guidance published to support antenatal and newborn (ANNB) screening providers in addressing inequalities throughout the screening pathway.
An evaluation of newborn blood spot screening for severe combined immunodeficiency (SCID) launches today in some parts of England.
Find out about the first child in the world to receive dietary treatment for phenylketonuria (PKU).
Public Health England (PHE) has published the fourth set of quarterly 2020 to 2021 key performance indicator (KPI) data for the NHS screening programmes.
Here are the dates when blood spot takers need to start offering parents and carers severe combined immunodeficiency (SCID) screening as part of an evaluation in England.
An evaluation is due to start on 6 September 2021 into screening babies for severe combined immunodeficiency (SCID) in England. This article describes some of the new resources for parents and professionals that have been developed for the evaluation and points you towards where you can find them.
We’re really pleased today to launch our new SCID screening e-learning resource.
An evaluation is due to start on 6 September 2021 into screening babies for severe combined immunodeficiency (SCID) in England. This article explains about a separate pathway for premature babies which have been screened for SCID as part of the evaluation.
PHE has public information leaflets for all NBS conditions, including the IMDs, to support parents throughout screening and diagnosis.